Approved innovative drugs with new targets or mechanisms (half year)
Total number of innovative drugs with novel biological targets or mechanisms of action approved for marketing.
Unit Count Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Approved innovative drugs with new targets or mechanisms (half year)
China, as of 30 Jun 2026
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| China 1 record | |||
| as of 30 Jun 2026 | 11 | NHSA · 30 Jun 2026 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元 | NHSA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Approved innovative drugs with new targets or mechanisms (half year). Retrieved from https://statorigin.org/indicators/approved-innovative-drugs-with-new-targets-or-mechanisms-half-year